Related references
Note: Only part of the references are listed.Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Retinoic Acid and Rapamycin Differentially Affect and Synergistically Promote the Ex Vivo Expansion of Natural Human T Regulatory Cells
Tatiana N. Golovina et al.
PLOS ONE (2011)
In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
Jaebok Choi et al.
BLOOD (2010)
Reprogrammed Foxp3+ Regulatory T Cells Provide Essential Help to Support Cross-presentation and CD8+ T Cell Priming in Naive Mice
Madhav D. Sharma et al.
IMMUNITY (2010)
Cutting Edge: The Th1 Response Inhibits the Generation of Peripheral Regulatory T Cells
David Caretto et al.
JOURNAL OF IMMUNOLOGY (2010)
Combined Administration of a Mutant TGF-β1/Fc and Rapamycin Promotes Induction of Regulatory T Cells and Islet Allograft Tolerance
Wensheng Zhang et al.
JOURNAL OF IMMUNOLOGY (2010)
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
Lionel Apetoh et al.
NATURE IMMUNOLOGY (2010)
Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3+ regulatory T cells
Roopali Gandhi et al.
NATURE IMMUNOLOGY (2010)
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures
Dat Q. Tran et al.
BLOOD (2009)
Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
Amy L. Putnam et al.
DIABETES (2009)
Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD
Christian Koenecke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
James L. Riley et al.
IMMUNITY (2009)
De Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid
Jun Wang et al.
JOURNAL OF IMMUNOLOGY (2009)
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
Xuyu Zhou et al.
NATURE IMMUNOLOGY (2009)
Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
Jochen Huehn et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells
Jason E. Foley et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells
Keli L. Hippen et al.
BLOOD (2008)
T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects
Jeffrey A. Bluestone et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin
Samik Basu et al.
JOURNAL OF IMMUNOLOGY (2008)
Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression
Sheng Xiao et al.
JOURNAL OF IMMUNOLOGY (2008)
被撤回的出版物: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo (Retracted article. See vol. 184, pg. 6556, 2010)
Suresh Radhakrishnan et al.
JOURNAL OF IMMUNOLOGY (2008)
Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero
Jeff E. Mold et al.
SCIENCE (2008)
Natural and TGF-β-induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other
David A. Horwitz et al.
TRENDS IN IMMUNOLOGY (2008)
Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype
Dat Q. Tran et al.
BLOOD (2007)
Vitamin a metabolites induce gut-homing FoxP3+ regulatory T cells
Seung G. Kang et al.
JOURNAL OF IMMUNOLOGY (2007)
What does the future hold for cell-based tolerogenic therapy?
Jeffrey A. Bluestone et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Maria-Grazia Roncarolo et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
Megan M. Suhoski et al.
MOLECULAR THERAPY (2007)
Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3
Luke M. Williams et al.
NATURE IMMUNOLOGY (2007)
FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type 1 receptor
T. Yamaguchi et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism
JE Foley et al.
JOURNAL OF IMMUNOLOGY (2005)
The Pim kinases control rapamycin-resistant T cell survival and activation
CJ Fox et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle
B Aghdasi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
